Resources for paediatric formulations.
- Published in:
- 2006
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2006 AND VI 20 AND IP 2
Results: 64
1
2
WHO analgesic ladder.
- Published in:
- 2006
- Publication type:
- Journal Article
3
WHO guidelines on avian influenza.
- Published in:
- 2006
- Publication type:
- Journal Article
4
Marketed unapproved drugs -- policy guide.
- Published in:
- 2006
- Publication type:
- Journal Article
5
New guidance for pharmacists on counterfeit medicines.
- Published in:
- 2006
- Publication type:
- Journal Article
6
Specifications for pharmaceutical preparations.
- Published in:
- 2006
- Publication type:
- Journal Article
7
Therapeutic guidelines for rheumatology.
- Published in:
- 2006
- Publication type:
- Journal Article
8
Interagency Emergency Health Kit 2006.
- Published in:
- 2006
- Publication type:
- Journal Article
9
Tissue infectivity and transmissible spongiform encephalopathies.
- Published in:
- 2006
- Publication type:
- Journal Article
10
EU regulation on compulsory licensing published.
- Published in:
- 2006
- Publication type:
- Journal Article
11
Resumed marketing of natalizumab.
- Published in:
- 2006
- Publication type:
- Journal Article
12
Withdrawal of marketing application for Surfaxin.
- Published in:
- 2006
- Publication type:
- Journal Article
13
Fluoxetine approved for children and adolescents.
- Published in:
- 2006
- Publication type:
- Journal Article
14
Rasagiline approved for Parkinson disease.
- Published in:
- 2006
- Publication type:
- Journal Article
15
Rapid approval of vaccine for prevention of cervical cancer.
- Published in:
- 2006
- Publication type:
- Journal Article
16
Topotecan/cisplatin for late-stage cervical cancer.
- Published in:
- 2006
- Publication type:
- Journal Article
17
Medical device innovation initiative.
- Published in:
- 2006
- Publication type:
- Journal Article
18
Decitabine approved for myelodysplastic syndromes.
- Published in:
- 2006
- Publication type:
- Journal Article
19
Bupropion approved for seasonal depression.
- Published in:
- 2006
- Publication type:
- Journal Article
20
EMEA Management Board moves for greater transparency.
- Published in:
- 2006
- Publication type:
- Journal Article
21
Transgenic antithrombin alfa approved.
- Published in:
- 2006
- Publication type:
- Journal Article
22
Adherence to WHO's Model List of Essential Medicines in two European countries.
- Published in:
- 2006
- Publication type:
- Journal Article
23
WHO Model List of Essential Medicines and developed countries: a comparison with the Lothian Joint Formulary.
- Published in:
- 2006
- Publication type:
- Journal Article
24
Gatifloxacin and blood glucose disturbances.
- Published in:
- 2006
- Publication type:
- Journal Article
25
Gadolinium-containing contrast agents and nephrogenic systemic fibrosis.
- Published in:
- 2006
- Publication type:
- Journal Article
26
ACE inhibitors and pregnancy.
- Published in:
- 2006
- Publication type:
- Journal Article
27
ACE inhibitors and birth defects.
- Published in:
- 2006
- Publication type:
- Journal Article
28
Update on status of contraceptive skin patch.
- Published in:
- 2006
- Publication type:
- Journal Article
29
Tenofovir and nonsteroidal anti-inflammatories: acute renal failure.
- Published in:
- 2006
- Publication type:
- Journal Article
30
International Conference of Drug Regulatory Authorities (ICDRA): recommendations.
- Published in:
- 2006
- Publication type:
- Journal Article
31
Drug regulation in 2006: vision and challenges.
- Published in:
- 2006
- Publication type:
- Journal Article
32
SSRI antidepressants linked to lung disorder in newborns.
- Published in:
- 2006
- Publication type:
- Journal Article
33
Resources for paediatric formulations.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 105
- Publication type:
- Article
34
WHO analgesic ladder.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 105
- Publication type:
- Article
35
WHO guidelines on avian influenza.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 104
- Publication type:
- Article
36
Marketed unapproved drugs -- policy guide.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 104
- Publication type:
- Article
37
New guidance for pharmacists on counterfeit medicines.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 104
- Publication type:
- Article
38
Specifications for pharmaceutical preparations.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 103
- Publication type:
- Article
39
Therapeutic guidelines for rheumatology.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 103
- Publication type:
- Article
40
Interagency Emergency Health Kit 2006.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 103
- Publication type:
- Article
41
Tissue infectivity and transmissible spongiform encephalopathies.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 91
- Publication type:
- Article
42
EU Regulation on compulsory licensing published.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 90
- Publication type:
- Article
43
Resumed marketing of natalizumab.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 90
- Publication type:
- Article
44
Decitabine approved for myelodysplastic syndromes.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 87
- Publication type:
- Article
45
Bupropion approved for seasonal depression.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 86
- Publication type:
- Article
46
Withdrawal of marketing application for Surfaxin.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 89
- Publication type:
- Article
47
EMEA Management Board moves for greater transparency.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 86
- Publication type:
- Article
48
Topotecan/cisplatin for late-stage cervical cancer.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 87
- Publication type:
- Article
49
Medical device innovation initiative.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 87
- Publication type:
- Article
50
Fluoxetine approved for children and adolescents.
- Published in:
- WHO Drug Information, 2006, v. 20, n. 2, p. 89
- Publication type:
- Article